Infusion Pumps | Market Insights | US | 2022
The US infusion pump market has been affected by the COVID-19 pandemic, restricting growth in the short term. Moderate growth is anticipated over the forecast period, driven by favorable demographics and the adoption of advanced products—including smart pumps with improved HCIT features and hybrid closed-loop insulin pumps—that command a premium price.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for infusion pumps in the US across a 11-year period.